Stability and compatibility of antibiotics in peritoneal dialysis solutions

Intraperitoneal (IP) administration of antibiotics is a preferred treatment of peritoneal dialysis (PD)-related peritonitis. Given the treatment duration of up to 2–3 weeks, it is important that robust data on antibiotic stability and compatibility are available to achieve notable treatment success....

Descripción completa

Detalles Bibliográficos
Autores principales: So, Simon Wai Yin, Chen, Lu, Woo, Alex Yuk Hei, Ng, Derek Man Him, Wong, Jennifer Ka Wah, Chow, Kai Ming, Runnegar, Naomi, Johnson, David W, Li, Philip Kam-Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
CKJ Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9155255/
https://www.ncbi.nlm.nih.gov/pubmed/35664278
http://dx.doi.org/10.1093/ckj/sfac012
Descripción
Sumario:Intraperitoneal (IP) administration of antibiotics is a preferred treatment of peritoneal dialysis (PD)-related peritonitis. Given the treatment duration of up to 2–3 weeks, it is important that robust data on antibiotic stability and compatibility are available to achieve notable treatment success. This article provides a comprehensive review of recent stability and compatibility studies pertaining to a wide range of antibiotics admixed in various PD solutions.

Ejemplares similares